---
layout: minimal-medicine
title: Stibophen
---

# Stibophen
### Generic Name
Stibophen

### Usage
Stibophen is an anthelmintic drug, meaning it's used to treat parasitic worm infestations.  Historically, its primary use was in the treatment of schistosomiasis, a parasitic disease caused by blood flukes (worms) of the genus *Schistosoma*.  However, it's important to note that Stibophen is largely obsolete for this purpose.  More effective and safer treatments, such as praziquantel, are now the standard of care for schistosomiasis.  Stibophen is rarely, if ever, used in modern medical practice.

### Dosage
Because Stibophen is no longer a commonly used medication, precise dosage information is difficult to obtain and should not be interpreted as a recommendation for use.  Any use of Stibophen requires strict medical supervision by a healthcare professional experienced in managing parasitic infections.  Dosage would have historically varied based on factors like the patient's age, weight, and the severity of the schistosomiasis infection,  and would have been determined on a case-by-case basis by a physician. Different forms of the medication may have existed (e.g., oral solution, injection), but details are scarce and outdated.

### Side Effects
Detailed information on the frequency and severity of Stibophen's side effects is limited due to its discontinued use. However, based on historical reports, potential side effects could include:

* Nausea
* Vomiting
* Abdominal discomfort
* Liver enzyme elevation
* Allergic reactions (ranging from mild skin rashes to severe anaphylaxis)


It's crucial to understand that this list may not be exhaustive, and serious, though uncommon, side effects may have occurred.  Because Stibophen is no longer used, comprehensive modern safety data is lacking.

### How it Works
Stibophen's mechanism of action involves the inhibition of phosphofructokinase, an enzyme crucial for glycolysis (the process of breaking down glucose for energy) in parasitic worms. By partially binding to the sulfhydryl (-SH) group of this enzyme, Stibophen disrupts the worm's energy production, leading to paralysis. The paralyzed worms lose their grip on the blood vessel walls, are shifted to the liver, eventually die, and are then removed by the body's immune system through phagocytosis.

### Precautions
Given Stibophen's obsolescence and the lack of readily available modern safety data, any potential use poses significant risk.  Extreme caution is warranted.  Contraindications (situations where the drug should not be used) and drug interactions are poorly documented.  Information regarding safe use in pregnant women, children, or the elderly is lacking and unreliable.  **Stibophen should not be used under any circumstances without the direct supervision of a physician specializing in tropical medicine or parasitic infections who has full knowledge of the risks involved.**

### FAQs

* **Q: Is Stibophen still used to treat schistosomiasis?**  A: No, Stibophen is obsolete for treating schistosomiasis and is replaced by safer and more effective medications like praziquantel.

* **Q: Where can I get Stibophen?** A:  Stibophen is not readily available in modern pharmacies.  Attempting to obtain it without a physician's prescription is strongly discouraged and could be unsafe.

* **Q: What are the long-term effects of Stibophen?** A:  Long-term effects are poorly documented due to the drug's discontinued use.  The potential for long-term consequences cannot be reliably assessed.

* **Q: Is Stibophen safe?** A: Given its obsolete status and lack of up-to-date safety data, Stibophen is considered unsafe for use except under extremely rare and strictly controlled circumstances by a specialist physician.


**Disclaimer:** This information is for educational purposes only and should not be considered medical advice.  Always consult a healthcare professional for any health concerns or before making any decisions related to your health or treatment.  The use of Stibophen is strongly discouraged due to its obsolescence and potential risks.
